Rozek Elizabeth, Chief Legal and Admin Officer at Sagimet Biosciences Inc. ($SGMT), made two open market sales of company shares over the past year, totaling about $112,500. Her most recent sale occurred on February 10, 2026. These sales rank 9,394th among 11,678 insiders, well below the average sale value of $8.6 million across 6.4 transactions per insider. She reported no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | Chief Legal & Admin. Officer | A | Stock Option (Right to Buy) | 88000 | $0.00 | 88,000.0000 | 32,464,893 | 9999.99% | 0.27% |
| Feb. 19, 2026 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | Chief Legal & Admin. Officer | A | Series A Common Stock | 44000 | $0.00 | 234,959.0000 | 32,464,893 | 23.04% | 0.14% |
| Feb. 10, 2026 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | Chief Legal & Admin. Officer | S | Series A Common Stock | 2622 | $5.36 | 190,959.0000 | 32,464,893 | 1.35% | 0.01% |
| Nov. 4, 2025 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | Chief Legal & Admin. Officer | A | Series A Common Stock | 9855 | $0.00 | 193,581.0000 | 32,464,893 | 5.36% | 0.03% |
| Nov. 4, 2025 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | Chief Legal & Admin. Officer | A | Stock Option (Right to Buy) | 13367 | $0.00 | 13,367.0000 | 32,464,893 | 9999.99% | 0.04% |
| July 21, 2025 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | General Counsel and CCO | S | Series A Common Stock | 10780 | $9.13 | 183,726.0000 | 32,195,366 | 5.54% | 0.03% |
| Feb. 6, 2025 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | General Counsel and CCO | A | Series A Common Stock | 34000 | $0.00 | 194,506.0000 | 31,350,725 | 21.18% | 0.11% |
| Feb. 6, 2025 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | General Counsel and CCO | A | Stock Option (Right to Buy) | 138000 | $0.00 | 138,000.0000 | 31,350,725 | 9999.99% | 0.44% |
| July 19, 2024 | Sagimet Biosciences Inc. | $SGMT | Rozek Elizabeth | General Counsel and CCO | S | Series A Common Stock | 10914 | $3.10 | 160,506.0000 | 31,913,887 | 6.37% | 0.03% |